Back to Superinvestors
SUPERINVESTOR HOLDERS
ROIV
Roivant Sciences Ltd
Healthcare · Biotechnology
- Holders
- 7
- Total value
- $1,177,778,218
- Total shares
- 33,300,591
- Cross-link
- Financials →
| Investor | Shares | Value | % of Portfolio | Activity | As of |
|---|---|---|---|---|---|
|
Tom Steyer
Farallon Capital Management LLC
|
14,309,000 | $506,395,510 | 2.35% | ADD +4,634,000 | 30 Jun 2026 |
|
Cliff Asness
AQR Capital Management
|
6,633,560 | $234,031,996 | 0.08% | ADD +686,702 | 30 Jun 2026 |
|
Andreas Halvorsen
Viking Global Investors
|
6,271,467 | $221,947,217 | 0.63% | REDUCE -380,981 | 30 Jun 2026 |
|
Lee Ainslie
Maverick Capital
|
2,829,024 | $100,119,159 | 0.88% | ADD +1,202,084 | 30 Jun 2026 |
|
Hersh Cohen
ClearBridge Investments
|
1,783,075 | $63,103,020 | 0.05% | REDUCE -222,490 | 30 Jun 2026 |
|
Joel Greenblatt
Gotham Asset Management
|
1,349,465 | $47,757,566 | 0.11% | REDUCE -66,626 | 30 Jun 2026 |
|
Ron Baron
Baron Capital (BAMCO)
|
125,000 | $4,423,750 | 0.01% | HOLD | 30 Jun 2026 |